Lisa de Jong — de research portal van de Rijksuniversiteit Groningen

Als u wijzigingen in Pure hebt gemaakt, zullen deze hier binnenkort zichtbaar zijn.

9 Article
2 Comment/Letter to the editor
1 Review article
1 Thesis fully internal (DIV)

Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings
de Jong, L. A., Groeneveld, J., Stevanovic, J., Rila, H., Tieleman, R. G., Huisman, M. V., Postma, M. J. & van Hulst, M., 31-mrt-2022, In: PLoS ONE. 17, 3, 5 blz., e0266625.
Onderzoeksoutput › Academic › peer review
Cost-minimisation analysis of a treat-and-extend regimen with anti-VEGFs in patients with neovascular age-related macular degeneration
Quist, S. W., de Jong, L. A., van Asten, F., Knoester, P., Postma, M. J. & Freriks, R. D., apr-2022, In: Graefe's Archive for Clinical and Experimental Ophthalmology. 260, blz. 1083–1095 12 blz.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand

16 Downloads (Pure)
Budget impact of optimizing rifaximin-alpha use for the prevention of recurrent hepatic encephalopathy in The Netherlands
de Jong, L. A., van Schoonhoven, A. V., Hofstra, H. S., Postma, M. J. & van Hoek, B., 9-okt-2021, In: Journal of Medical Economics. 24, 1, blz. 1149-1163 15 blz.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand

33 Downloads (Pure)
Author's Reply: Response to_ Defining comparators according to IQWIG’s efficiency-frontier method
van der Pol, S., Jong, de, L., Vemer, P., Jansen, D. & Postma, M., 1-mei-2020, In: Value in Health. 23, 5, blz. 675-676 2 blz.
Onderzoeksoutput › Academic

Open Access
Bestand

13 Downloads (Pure)
Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands
Gout-Zwart, J. J., de Jong, L. A., Saptenno, L. & Postma, M. J., jun-2020, In: PharmacoEconomics - open. 4, 2, blz. 321-330 10 blz.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand

83 Downloads (Pure)

Budget impact of optimizing rifaximin-α use for the prevention of recurrent hepatic encephalopathy in The Netherlands
de Jong, L. (Contributor), van Schoonhoven, A. (Contributor), Hofstra, H. S. (Contributor), Postma, M. (Contributor) & van Hoek, B. (Contributor), figshare Academic Research System, 9-okt-2021
DOI: 10.6084/m9.figshare.16779043.v1, https://tandf.figshare.com/articles/dataset/Budget_impact_of_optimizing_rifaximin-_use_for_the_prevention_of_recurrent_hepatic_encephalopathy_in_The_Netherlands/16779043/1
Dataset